

Cover Story
By Claire Dietz
If the June 22 Senate appropriations hearing is an indication, President Donald Trump will encounter considerable difficulty in accomplishing his stated goal of cutting the NIH budget by 21 percent in fiscal 2018.
By Matthew Bin Han Ong
In Brief
Drugs & Targets


Trending Stories
- Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say - Trump’s FDA invents an unusual regulatory pathway to approve leucovorin for autism
Experts call the move “extremely premature” - With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shutdown
- Bhattacharya: New grant review criterion is “not political”
- Population-based cancer surveillance is a national treasure at risk
- Ci4CC’s 24th Symposium & Workshop set to focus on precision oncology powered by data intelligence